StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by AngelMan92on Aug 10, 2020 12:55pm

172 Views

Post# 31388085

RE:RE:Q2 release

I would find it odd if they chose to release Q2 on the 14th, was honestly expecting it by tomorrow (cuz this company fetishizes giving all their news in the beginning of the week) , but hey if it's scheduled it's scheduled. You hype?

LithLover wrote: You created a new account just to ask when Q2 is coming out? It took longer to create your account than to find this link:

https://www.osc.gov.on.ca/en/Companies_filing-calendar_index.htm

Q2 is due Aug 14, The AGM is Aug 17, Q3 Nov 16

MathDe wrote: Hello, where did they annonced Q2 release, can't find anything on their website